Статті в журналах з теми "Vaccines Victoria Safety measures"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Vaccines Victoria Safety measures".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Chang, Lee-Jah, Ya Meng, Helene Janosczyk, Victoria Landolfi, and H. Keipp Talbot. "LB14. Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older." Open Forum Infectious Diseases 5, suppl_1 (November 2018): S764. http://dx.doi.org/10.1093/ofid/ofy229.2188.
Повний текст джерела&NA;. "Additional safety measures for HPV vaccines in Japan." Reactions Weekly &NA;, no. 1413 (August 2012): 2. http://dx.doi.org/10.2165/00128415-201214130-00004.
Повний текст джерелаKostinov, Mikhail P., Alexander P. Cherdantsev, Nelli K. Akhmatova, Daria A. Praulova, Aristitsa M. Kostinova, Elina A. Akhmatova, and Evgeniia O. Demina. "Immunogenicity and safety of subunit influenza vaccines in pregnant women." ERJ Open Research 4, no. 2 (April 2018): 00060–2017. http://dx.doi.org/10.1183/23120541.00060-2017.
Повний текст джерелаAhn, Tae Kyu, Soo Kang, Jin Hui Paik, and Young Ho Seo. "Adverse events and preventive measures related to COVID-19 vaccines." Clinical and Experimental Emergency Medicine 8, no. 3 (September 30, 2021): 153–59. http://dx.doi.org/10.15441/ceem.21.067.
Повний текст джерелаSattar, Naw Safrin, and Shaikh Arifuzzaman. "COVID-19 Vaccination Awareness and Aftermath: Public Sentiment Analysis on Twitter Data and Vaccinated Population Prediction in the USA." Applied Sciences 11, no. 13 (June 30, 2021): 6128. http://dx.doi.org/10.3390/app11136128.
Повний текст джерелаIbrahim, Mohammad Nabil, David B. Logan, Sjaan Koppel, and Brian Fildes. "Fatal and Serious Injury Rates for Different Travel Modes in Victoria, Australia." Sustainability 14, no. 3 (February 8, 2022): 1924. http://dx.doi.org/10.3390/su14031924.
Повний текст джерелаKent, Helen, Margaret E. Heffernan, Julie Silvers, Elya Moore, and Suzanne M. Garland. "Role of the nurse immuniser in implementing and maintaining the National Human Papillomavirus 'Cervical Cancer' Vaccine rollout through a school-based program in Victoria." Sexual Health 7, no. 3 (2010): 391. http://dx.doi.org/10.1071/sh09148.
Повний текст джерелаSharma, Eshani, Sraddha Revinipati, Saisha Bhandari, Sejal Thakur, Shubham Goyal, Aruni Ghose, Sukrit Bajpai, Waleed Muhammad, and Stergios Boussios. "Efficacy and Safety of COVID-19 Vaccines—An Update." Diseases 10, no. 4 (November 23, 2022): 112. http://dx.doi.org/10.3390/diseases10040112.
Повний текст джерелаAssefa, Ayalew, and Fufa Abunna. "Maintenance of Fish Health in Aquaculture: Review of Epidemiological Approaches for Prevention and Control of Infectious Disease of Fish." Veterinary Medicine International 2018 (2018): 1–10. http://dx.doi.org/10.1155/2018/5432497.
Повний текст джерелаCheng, Daryl R., Hazel J. Clothier, Hannah J. Morgan, Emma Roney, Priya Shenton, Nicholas Cox, Bryn O. Jones, Silja Schrader, Nigel W. Crawford, and Jim P. Buttery. "Myocarditis and myopericarditis cases following COVID-19 mRNA vaccines administered to 12–17-year olds in Victoria, Australia." BMJ Paediatrics Open 6, no. 1 (June 2022): e001472. http://dx.doi.org/10.1136/bmjpo-2022-001472.
Повний текст джерелаHassan, Taimoor, and Saleha Saleha. "PAKISTAN’S PERSPECTIVE ON COVID-19 VACCINES." Gomal Journal of Medical Sciences 19, no. 3 (September 30, 2021): 111–16. http://dx.doi.org/10.46903/gjms/19.03.1016.
Повний текст джерелаTian, Yan, Long Chen, and Yuan Shi. "Safety, Efficacy, and Immunogenicity of Varying Types of COVID-19 Vaccines in Children Younger Than 18 Years: An Update of Systematic Review and Meta-Analysis." Vaccines 11, no. 1 (December 30, 2022): 87. http://dx.doi.org/10.3390/vaccines11010087.
Повний текст джерелаGlass, Deborah, Christina Dimitriadis, Jessy Hansen, Fiona Hore-Lacy, Malcolm R. Sim, and Ryan F. Hoy. "Changes to Silica Exposure Control Measures in the Artificial Stone Benchtop Industry in Victoria Australia." Safety and Health at Work 13 (January 2022): S25. http://dx.doi.org/10.1016/j.shaw.2021.12.786.
Повний текст джерелаTang, Kuo-Tung, Bo-Chueh Hsu, and Der-Yuan Chen. "Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines in Rheumatic Patients: An Updated Systematic Review and Meta-Analysis." Biomedicines 10, no. 4 (April 1, 2022): 834. http://dx.doi.org/10.3390/biomedicines10040834.
Повний текст джерелаKrakowczyk, Julia Barbara, Alexander Bäuerle, Lars Pape, Theodor Kaup, Laura Nulle, Martin Teufel, and Eva-Maria Skoda. "COVID-19 Vaccine for Children: Vaccination Willingness of Parents and Its Associated Factors—A Network Analysis." Vaccines 10, no. 7 (July 20, 2022): 1155. http://dx.doi.org/10.3390/vaccines10071155.
Повний текст джерелаPrincipi, Nicola, and Susanna Esposito. "Is the Immunization of Pregnant Women against COVID-19 Justified?" Vaccines 9, no. 9 (August 30, 2021): 970. http://dx.doi.org/10.3390/vaccines9090970.
Повний текст джерелаShimasaki, Noriko, Junko Ishii, Tomoko Kuwahara, and Haruna Nishijima. "A Brief Questionnaire on Healthcare Workers’ Awareness Toward the COVID-19 Vaccine and Antibody Tests." Journal of Disaster Research 18, no. 1 (January 20, 2023): 21–26. http://dx.doi.org/10.20965/jdr.2023.p0021.
Повний текст джерелаWu, Tsu-Yin, Olivia Ford, Alice Jo Rainville, Xining Yang, Chong Man Chow, Sarah Lally, Rachel Bessire, and Jessica Donnelly. "Perceptions of COVID-19 Vaccine, Racism, and Social Vulnerability: An Examination among East Asian Americans, Southeast Asian Americans, South Asian Americans, and Others." Vaccines 10, no. 8 (August 17, 2022): 1333. http://dx.doi.org/10.3390/vaccines10081333.
Повний текст джерелаJiménez-Cabello, Luis, Sergio Utrilla-Trigo, Eva Calvo-Pinilla, Sandra Moreno, Aitor Nogales, Javier Ortego, and Alejandro Marín-López. "Viral Vector Vaccines against Bluetongue Virus." Microorganisms 9, no. 1 (December 25, 2020): 42. http://dx.doi.org/10.3390/microorganisms9010042.
Повний текст джерелаMarra, Yasmin, and Fawziah Lalji. "Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines." Viruses 14, no. 12 (November 29, 2022): 2667. http://dx.doi.org/10.3390/v14122667.
Повний текст джерелаMohamed Bulla, Haghamad Allzain. "COVID -19: EFFICACY AND SAFETY PROFILE OF MAIN VACCINES APPROVED FOR EMERGENCY USE AUTHORIZATION IN 2021." International Journal of Research -GRANTHAALAYAH 9, no. 7 (August 7, 2021): 271–83. http://dx.doi.org/10.29121/granthaalayah.v9.i7.2021.4062.
Повний текст джерелаAnnas, Salleh, and Mohd Zamri-Saad. "Intranasal Vaccination Strategy to Control the COVID-19 Pandemic from a Veterinary Medicine Perspective." Animals 11, no. 7 (June 24, 2021): 1876. http://dx.doi.org/10.3390/ani11071876.
Повний текст джерелаAgyekum, Martin Wiredu, Grace Frempong Afrifa-Anane, Frank Kyei-Arthur, and Bright Addo. "Acceptability of COVID-19 Vaccination among Health Care Workers in Ghana." Advances in Public Health 2021 (April 16, 2021): 1–8. http://dx.doi.org/10.1155/2021/9998176.
Повний текст джерелаSchulze-Koops, Hendrik, Christof Specker, and Alla Skapenko. "Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines." RMD Open 7, no. 1 (February 2021): e001553. http://dx.doi.org/10.1136/rmdopen-2020-001553.
Повний текст джерелаOlivieri, Bianca, Corrado Betterle, and Giovanna Zanoni. "Vaccinations and Autoimmune Diseases." Vaccines 9, no. 8 (July 22, 2021): 815. http://dx.doi.org/10.3390/vaccines9080815.
Повний текст джерелаKrasilnikova, Anna. "Brief Overview of the Currently Available COVID-19 Vaccines." Journal of Clinical and Health Sciences 7, no. 1 (February 23, 2022): 5. http://dx.doi.org/10.24191/jchs.v7i1.14658.
Повний текст джерелаMikshis, N. I., P. Yu Popova, A. P. Semakova, and V. V. Kutyrev. "LICENSED ANTHRAX VACCINES AND EXPERIMENTAL PREPARATIONS AT THE STAGE OF CLINICAL TRIALS." Journal of microbiology epidemiology immunobiology, no. 4 (August 28, 2017): 112–26. http://dx.doi.org/10.36233/0372-9311-2017-4-112-126.
Повний текст джерелаCole, Abimbola, Peggy Webster, Denny Van Liew, Maribel Salas, Omar Aimer, and Marina A. Malikova. "Safety surveillance and challenges in accelerated COVID-19 vaccine development." Therapeutic Advances in Drug Safety 13 (January 2022): 204209862211164. http://dx.doi.org/10.1177/20420986221116452.
Повний текст джерелаBalashov, A. N., D. A. Lozovoy, A. V. Borisov, D. V. Mikhalishin, and M. I. Doronin. "ASSESSMENT OF EFFICACY AND SAFETY OF INACTIVATED RABIES VACCINES BASED ON “ARRIAH” STRAIN AND FORMULATED WITH DIFFERENT ADJUVANTS IN CATTLE." Veterinary Science Today, no. 4 (December 26, 2019): 37–42. http://dx.doi.org/10.29326/2304-196x-2019-4-31-37-42.
Повний текст джерелаKhishov, Andrey S., and Galina I. Burlakova. "Vaccines for aquaculture overview." Veterinaria Kubani, no. 5 (October 30, 2020): 42–43. http://dx.doi.org/10.33861/2071-8020-2020-5-42-43.
Повний текст джерелаFolorunso, Olufemi Samuel, and Olihile M. Sebolai. "Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines." Vaccines 8, no. 3 (June 27, 2020): 341. http://dx.doi.org/10.3390/vaccines8030341.
Повний текст джерелаPunsalan, Mairre Louie D., and Angelyn T. Salunga. "Mask is a must: the need of protection and safety against COVID-19." Journal of Public Health 43, no. 2 (March 26, 2021): e379-e380. http://dx.doi.org/10.1093/pubmed/fdab077.
Повний текст джерелаSoares, Patricia, João Victor Rocha, Marta Moniz, Ana Gama, Pedro Almeida Laires, Ana Rita Pedro, Sónia Dias, Andreia Leite, and Carla Nunes. "Factors Associated with COVID-19 Vaccine Hesitancy." Vaccines 9, no. 3 (March 22, 2021): 300. http://dx.doi.org/10.3390/vaccines9030300.
Повний текст джерелаPoston, Sara. "Vaccination in Older Adults: The When and Where." Innovation in Aging 4, Supplement_1 (December 1, 2020): 806. http://dx.doi.org/10.1093/geroni/igaa057.2928.
Повний текст джерелаAl-Qahtani, Wedad Saeed, and Fatmah Ahmed Alsafhi. "A Commentary on Realities of Developing COVID-19 Vaccines Discussed through the Global Health Safety Perspective." Vaccines 9, no. 3 (March 18, 2021): 274. http://dx.doi.org/10.3390/vaccines9030274.
Повний текст джерелаStampoltzi, Aglaia, Εrene Stylianaki, and Εfstratia Stavrinou. "Parents’ perceptions and views regarding vaccination: A pilot survey of parents-healthcare professionals and parents non-healthcare professionals." Hellenic Journal of Nursing Science 13, no. 4 (December 31, 2020): 60–71. http://dx.doi.org/10.24283/hjns.202046.
Повний текст джерелаDiamond, Michael S., Julie E. Ledgerwood, and Theodore C. Pierson. "Zika Virus Vaccine Development: Progress in the Face of New Challenges." Annual Review of Medicine 70, no. 1 (January 27, 2019): 121–35. http://dx.doi.org/10.1146/annurev-med-040717-051127.
Повний текст джерелаHashem, Anwar M., Abdullah Algaissi, Anurodh Shankar Agrawal, Sawsan S. Al-amri, Rowa Y. Alhabbab, Sayed S. Sohrab, Abdulrahman S. Almasoud, et al. "A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model." Journal of Infectious Diseases 220, no. 10 (July 4, 2019): 1558–67. http://dx.doi.org/10.1093/infdis/jiz137.
Повний текст джерелаSinghal, Jyoti, and Neamat ElGayar. "SENTIMENT ANALYSIS OF COVID-19 VACCINE TWEETS." International Research Journal of Computer Science 9, no. 4 (April 30, 2022): 61–88. http://dx.doi.org/10.26562/irjcs.2021.v0904.003.
Повний текст джерелаG, Zewdie. "A Review on: Lumpy Skin Disease: Enhance Awareness on the Epidemiological situation and Diagnosis; Prevention and Control Measures in Ethiopia." Virology & Immunology Journal 5, no. 1 (January 12, 2021): 1–11. http://dx.doi.org/10.23880/vij-16000268.
Повний текст джерелаEibl, Dieter, Martin Sievers, Regine Eibl, Martin Bachmann, Senta Walton, Nik Keel, Gilles Richner, et al. "Keeping SARS-CoV-2 out: Vaccines, Filters, and Self-disinfecting Textiles." CHIMIA International Journal for Chemistry 75, no. 3 (March 31, 2021): 215–18. http://dx.doi.org/10.2533/chimia.2021.215.
Повний текст джерелаShehata, Awad A., Rokshana Parvin, Abdou Nagy, Ya Wang, Turki Maher Azhar, Youssef A. Attia, Esam I. Azhar, Alok K. Paul, and M. Rahmatullah. "An overview of the ongoing challenges in SARS-CoV-2 global control." German Journal of Microbiology 1, no. 2 (2021): 1–18. http://dx.doi.org/10.51585/gjm.2021.2.0006.
Повний текст джерелаNasrun, Mastika, Norazlina Abdul Aziz, Nurasma Yahaya, and Sarah Munirah Abdullah. "Legal Challenges of the Covid-19 Vaccination Program: A Comparative Discourse between Malaysia and Australia." Malaysian Journal of Social Sciences and Humanities (MJSSH) 6, no. 10 (October 10, 2021): 319–33. http://dx.doi.org/10.47405/mjssh.v6i10.1078.
Повний текст джерелаPrymula, Roman. "Controversies in Vaccination." European Review 21, S1 (July 2013): S56—S61. http://dx.doi.org/10.1017/s1062798713000227.
Повний текст джерелаChang, Leejah, Evan J. Anderson, Robert Jeanfreau, Ying He, Bryony Hicks, Anju Shrestha, Aseem Pandey, Rawia Khoury, Iris De Bruijn, and Victoria Landolfi. "160. Safety and Immunogenicity of Escalating Dose Formulations of High-dose Quadrivalent Influenza Vaccine in Children 6 Months Through < 18 Years of Age." Open Forum Infectious Diseases 7, Supplement_1 (October 1, 2020): S209—S210. http://dx.doi.org/10.1093/ofid/ofaa439.470.
Повний текст джерелаBazhenova, Aleksandra, Fang Gao, Barbara Bolgiano, and Stephen E. Harding. "Glycoconjugate vaccines against Salmonella enterica serovars and Shigella species: existing and emerging methods for their analysis." Biophysical Reviews 13, no. 2 (April 2021): 221–46. http://dx.doi.org/10.1007/s12551-021-00791-z.
Повний текст джерелаPogostin, Brett H., and Kevin J. McHugh. "Novel Vaccine Adjuvants as Key Tools for Improving Pandemic Preparedness." Bioengineering 8, no. 11 (October 24, 2021): 155. http://dx.doi.org/10.3390/bioengineering8110155.
Повний текст джерелаSanyaolu, Adekunle, Chuku Okorie, Aleksandra Marinkovic, Stephanie Prakash, Martina Williams, Nafees Haider, Jasmine Mangat, et al. "Current advancements and future prospects of COVID-19 vaccines and therapeutics: a narrative review." Therapeutic Advances in Vaccines and Immunotherapy 10 (January 2022): 251513552210975. http://dx.doi.org/10.1177/25151355221097559.
Повний текст джерелаZhao, Yi-Miao, Lin Liu, Jie Sun, Wei Yan, Kai Yuan, Yong-Bo Zheng, Zheng-An Lu, et al. "Public Willingness and Determinants of COVID-19 Vaccination at the Initial Stage of Mass Vaccination in China." Vaccines 9, no. 10 (October 13, 2021): 1172. http://dx.doi.org/10.3390/vaccines9101172.
Повний текст джерелаZhao, Yi-Miao, Lin Liu, Jie Sun, Wei Yan, Kai Yuan, Yong-Bo Zheng, Zheng-An Lu, et al. "Public Willingness and Determinants of COVID-19 Vaccination at the Initial Stage of Mass Vaccination in China." Vaccines 9, no. 10 (October 13, 2021): 1172. http://dx.doi.org/10.3390/vaccines9101172.
Повний текст джерела